Oxford Nanopore reels in $109M to ramp up R&D

U.K. diagnostics outfit Oxford Nanopore raked in £70 million ($109 million) through a private placement of ordinary shares, with new and existing investors in the U.K., U.S. and Europe contributing financing. The funds will be used to beef up the company's portfolio and fuel R&D, including marketing and development for its electronic molecular analysis systems, the company said in a statement. Counting its latest financing, Oxford Nanopore has raised about £251 million to date. Statement

Suggested Articles

Grail published new data showing that its cancer-screening blood test is now able to spot more than 50 types of the disease and across all stages.

Battelle received an emergency go-ahead from the FDA over the weekend to deploy its decontamination system for N95 respirator masks.

The limited supply of ventilators is one of the chief concerns facing hospitals as they prepare for more COVID-19 cases.